Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of ...

Retrieved on: 2021-11-03 00:33:57

Tags for this article:

Click the tags to see associated articles and topics

Landos Biopharma Announces FDA Clearance of its IND for LABP-104 for the Treatment of .... View article details on hiswai:

Excerpt

02, 2021 (GLOBE NEWSWIRE) -- Landos Biopharma, Inc. (NASDAQ: LABP), a late clinical-stage biopharmaceutical company utilizing its LANCE® Advanced ...

Article found on: www.yahoo.com